(Q39414184)

11 September 2017

title

"Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients (English)

1 reference

11 September 2017

1 reference

Jackson K

1

1 reference

11 September 2017

Ashby M

2

1 reference

11 September 2017

Martin P

3

1 reference

11 September 2017

Pisasale M

4

1 reference

11 September 2017

Brumley D

5

1 reference

11 September 2017

Hayes B

6

1 reference

11 September 2017

publication date

1 October 2001

1 reference

Journal of Pain and Symptom Management

11 September 2017

published in

1 reference

11 September 2017

volume

22

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

834-842

1 reference

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

A prospective multicenter assessment of the Edmonton staging system for cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Spinal cord pharmacology of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Somatic pain–pathogenesis and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Continuous subcutaneous injection of ketamine for cancer pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Low-dose subcutaneous ketamine infusion and morphine tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Ketamine as an adjunct to morphine in the treatment of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

The visual analogue pain intensity scale: what is moderate pain in millimetres?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Description of a mechanistic approach to pain management in advanced cancer. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

N of 1 randomised controlled trials of oral ketamine in patients with chronic pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900340-2

7 January 2021

10.1016/S0885-3924(01)00340-2

Identifiers

DOI

1 reference

11 September 2017

1 reference